Significance of predictive models / risk calculators for HBV-related hepatocellular carcinoma

Dong Jing; Jiang JiaJi

doi:10.3969/j.issn.1001-5256.2015.06.008

Issue 6

Jun. 2015

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2015 > 31(6): 855-858

PDF( 1481 KB)

Significance of predictive models / risk calculators for HBV-related hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2015.06.008

Published Date: 2015-06-20

Abstract

Abstract

Hepatitis B virus( HBV)- related hepatocellular carcinoma( HCC) is a major public health problem in Southeast Asia. In recent years,researchers from Hong Kong and Taiwan have reported predictive models or risk calculators for HBV- associated HCC by studying its natural history,which,to some extent,predicts the possibility of HCC development. Generally,risk factors of each model involve age,sex,HBV DNA level,and liver cirrhosis. This article discusses the evolution and clinical significance of currently used predictive models for HBV- associated HCC and assesses the advantages and limits of risk calculators. Updated REACH- B model and LSM- HCC model show better negative predictive values and have better performance in predicting the outcomes of patients with chronic hepatitis B( CHB). These models can be applied to stratified screening of HCC and,meanwhile,become an assessment tool for the management of CHB patients.
- carcinoma,hepatocellular,
- hepatitis B virus,
- proportional hazards models

FullText(HTML)

References(17)

References

[1]MITTAL S,El-SERAG HB.Epidemiology of hepatocellular carcinoma:consider the population[J].J Clin Gastroenterol,2013,47(Suppl):s2-s6.

[2]WONG GL,WONG VW,TAN GM,et al.Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis[J].Liver Int,2008,28(1):79-87.

[3] BRUIX J,SHERMAN M.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53(3):1020-1022.

[4]YUEN MF,TANAKA Y,FONG DY,et al.Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B[J].J Hepatol,2009,50(1):80-88.

[5]YANG JD,KIM WR,COELHO R,et al.Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma[J].Clin Gastroenterol Hepatol,2011,9(1):64-70.

[6]HAN KH,AHN SH.How to predict HCC development in patients with chronic B viral liver disease?[J].Intervirology,2005,48(1):23-28.

[7] WONG VW,CHAN SL,MO F,et al.Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers[J].J Clin Oncol,2010,28(10):1660-1665.

[8]WONG GL,CHAN HL,WONG CK,et al.Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B[J].J Hepatol,2014,60(2):339-345.

[9]YANG HI,SHERMAN M,SU J,et al.Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection[J].J Clin Oncol,2010,28(14):2437-2244.

[10]YANG HI,YUEB MF,CHAN HL,et al.Risk estimation for hepatocellular carcinoma in chronic hepatitis B(REACH-B):development and validation of a predictive score[J].Lancet Oncol,2011,12(6):568-574.

[11]LEE MH,YANG HI,LIU J,et al.Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients:risk scores integrating host and virus profiles[J].Hepatology,2013,58(2):546-554.

[12]PAPATHEODORIDIS GV,DALEKOS GN,YURDAYDIN C,et al.Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir[J].J Hepatol,2015,62(2):363-370.

[13]YANG HI,LEE MH,LIU J,et al.Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia[J].World J Gastroenterol,2014,20(20):6244-6251.

[14]KAO JH.Risk stratification of HBV infection in Asia-Pacific region[J].Clin Mol Hepatol,2014,20(3):223-227.

[15]WONG GL,CHAN HL,CHAN H,et al.Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment[J].Gastroenterology,2013,144(5):933-944.

[16]COFFIN CS,REZAEEAVAL M,PANG JX,et al.The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy[J].Aliment Pharmacol Ther,2014,40(11-12):1262-1269.

[17]DONG J,JIANG JJ.Screening and the effect of antiviral therapy for hepatitis B virus related hepatocellular carcinoma[J].Chin J Viral Dis,2013,3(6):474-479.(in Chinese)董菁,江家骥.乙型肝炎病毒相关性肝细胞癌的筛查及抗病毒治疗的应用[J].中国病毒病杂志,2013,3(6):474-479.

Relative Articles

[1]	Ruitao YANG, Rui YANG, Xun DENG, Senxiang ZENG, Xiaoyan YANG. Diagnosis and treatment principles of liver injury induced by antithyroid drugs[J]. Journal of Clinical Hepatology, 2024, 40(3): 621-625. doi: 10.12449/JCH240331
[2]	Guojing XING, Longlong LUO, Lifei WANG, Shunna WANG, Xiaofeng ZHENG, Lixia LU, Jiucong ZHANG. Role of mesenchymal stem cells and their exosomes in the treatment of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(3): 633-638. doi: 10.12449/JCH240333
[3]	Rui CHEN, Zhixin WANG, Haining FAN, Haijiu WANG. Research advances in the role of lymphocyte activation gene-3 in liver-related diseases[J]. Journal of Clinical Hepatology, 2021, 37(4): 977-981. doi: 10.3969/j.issn.1001-5256.2021.04.056
[4]	Hou JunXing, Yan FenQin, Yu YueCheng. The pathogenesis,diagnosis,and treatment of drug-induced liver injury with extrahepatic adverse drug reactions[J]. Journal of Clinical Hepatology, 2020, 36(3): 497-500. doi: 10.3969/j.issn.1001-5256.2020.03.003
[5]	Jing Jing, He TingTing, Wang RuiLin, Zhang Fan, Niu Ming, Guo YuMing, Zhu Yun, Xiao XiaoHe, Wang JiaBo. Detection of the risk signals of drug-induced liver injury: Challenges and advances[J]. Journal of Clinical Hepatology, 2020, 36(3): 491-496. doi: 10.3969/j.issn.1001-5256.2020.03.002
[6]	Huang Ang, Sun Ying, Zou ZhengSheng. Recent research advances in chronicity of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 501-504. doi: 10.3969/j.issn.1001-5256.2020.03.004
[7]	Xiao XiaoHe. Combination of medicine and pharmacy assists for precise prevention and control of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 489-490. doi: 10.3969/j.issn.1001-5256.2020.03.001
[8]	Yang Xue, Tu RongFang, Yang JinHui. Research advances in drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 509-513. doi: 10.3969/j.issn.1001-5256.2020.03.006
[9]	Ye LiHong, Wang ChongKui, Shao Chen, Zhang HaiCong, Liu ZhiQuan, Wang TaiLing. Clinical and biochemical features of bile duct injury type of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(5): 1059-1064. doi: 10.3969/j.issn.1001-5256.2020.05.022
[10]	Liu Meng, Yang XuanZi, Yu LeCheng. Current status of the pathogenesis, diagnosis, and treatment of drug-induced cholestasis[J]. Journal of Clinical Hepatology, 2019, 35(2): 252-257. doi: 10.3969/j.issn.1001-5256.2019.02.003
[11]	Han Ying, Chen Jie, Dan Jing, Liu YanMin, Zhang XiaoDan, Ren MeiXin, Du XiaoFei, Bian XinQu, Liu Dan, Huang YunLi, Huang ChunYang, Liao HuiYu. Value of fumarate hydratase antibody in differential diagnosis of autoimmune hepatitis and drug-induced liver injury[J]. Journal of Clinical Hepatology, 2019, 35(6): 1326-1329. doi: 10.3969/j.issn.1001-5256.2019.06.029
[12]	Kong XiaoLu, Shao Xue, Li DongFu. Senile intestinal lymphangiectasia with drug-induced liver injury: A case report[J]. Journal of Clinical Hepatology, 2019, 35(8): 1800-1802. doi: 10.3969/j.issn.1001-5256.2019.08.030
[13]	Bian ZhaoLian, Shao JianGuo, Ma Xiong. Differential diagnosis of drug-induced liver injury and autoimmune hepatitis and related therapeutic strategies[J]. Journal of Clinical Hepatology, 2018, 34(6): 1156-1159. doi: 10.3969/j.issn.1001-5256.2018.06.003
[14]	Yu LeCheng, Fan Ye, Chen ChengWei. Diagnosis and treatment of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2018, 34(6): 1160-1165. doi: 10.3969/j.issn.1001-5256.2018.06.004
[15]	Chou LiXia, Fan ZuoPeng, Liu Ying, Liang Shan, Nie Wei, Lin Wei, Liu YiRong, Zhang Jing, Hu ZhongJie. Application of a modified diagnostic scale in diagnosis of acute drug-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(7): 1328-1331. doi: 10.3969/j.issn.1001-5256.2017.07.025
[16]	Ji ChenHua, Zhang ZhuQing, Wang XiaoYuan, Lu ShuMing. Clinical features of elderly patients with drug-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(3): 502-506. doi: 10.3969/j.issn.1001-5256.2017.03.021
[17]	Zhang Dong, Zhang Tao, Wu YuNan, Sun KeWei. A systematic analysis of the application of diagnostic criteria for drug-induced liver injury in China based on the literature[J]. Journal of Clinical Hepatology, 2017, 33(5): 919-923. doi: 10.3969/j.issn.1001-5256.2017.05.026
[18]	Yuan Ling, Yang YongGeng, Shen YouXiu, Ma YingCai. Research advances in drug- induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(2): 375-378. doi: 10.3969/j.issn.1001-5256.2017.02.038
[19]	Yu YueCheng, Fan Ye. Advances in Roussel Uclaf Causality Assessment Method for diagnosis of drug-induced liver injury and its comparison with structured expert opinion process[J]. Journal of Clinical Hepatology, 2016, 32(9): 1706-1713. doi: 10.3969/j.issn.1001-5256.2016.09.014
[20]	Lu Yi, Yu Hui. Discussion on idiosyncratic drug-induced liver injury in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1215-1217. doi: 10.3969/j.issn.1001-5256.2015.08.008

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2990) PDF downloads(576)

Significance of predictive models / risk calculators for HBV-related hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2015.06.008

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Significance of predictive models / risk calculators for HBV-related hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2015.06.008

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content